We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Validates Cumberland’s Patent for Overdose Drug Acetadote in Dispute with Mylan
Court Validates Cumberland’s Patent for Overdose Drug Acetadote in Dispute with Mylan
The U.S. Court of Appeals for the Federal Circuit affirmed Cumberland Pharmaceuticals’ patent for its second-generation version of Acetadote, barring Mylan from marketing a generic of the overdose therapy.